Cannabidiol (CBD) for the treatment of bipolar affective disorder (2007)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; QUEIROZ, REGINA HELENA COSTA - FCFRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidades: FMRP; FCFRP
- Subjects: TRANSTORNO BIPOLAR; CANNABIS
- Language: Inglês
- Imprenta:
- Publisher: International Cannabinoid Research Society
- Publisher place: Québec
- Date published: 2007
- Source:
- Título: Program and Abstracts
- Conference titles: Annual Symposium on the Cannabinoids
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol (CBD) for the treatment of bipolar affective disorder. 2007, Anais.. Québec: International Cannabinoid Research Society, 2007. . Acesso em: 13 fev. 2026. -
APA
Crippa, J. A. de S., Hallak, J. E. C., Vilela, J. A. A., Morais, S. L., Sanches, R. F., Malfará, W., et al. (2007). Cannabidiol (CBD) for the treatment of bipolar affective disorder. In Program and Abstracts. Québec: International Cannabinoid Research Society. -
NLM
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2026 fev. 13 ] -
Vancouver
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2026 fev. 13 ] - Safety and side effects of cannabidiol, a Cannabis sativa constituent
- Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
- Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients
- Anxiolytic effect of cannabidiol in subjects with social anxiety disorder
- Development and validation of a liquid-liquid extraction and gas chromatography/mass spectrometry methodology for cannabidiol analysis in human plasma
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
